MedPath

Plasma exchange for lung haemorrhages in leptospirosis

Phase 3
Conditions
eptospirosis
Registration Number
SLCTR/2018/013
Lead Sponsor
Dr Nalaka Herath
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Age 15 to 80 , with lung hemorrhages due to leptospirosis.

Diagnosis of leptospirosis: Patients with a clinical picture suggestive of leptospirosis and confirmed with PCR, MAT or both)

Definition of leptospirosis associated pulmonary hemorrhage: Patient with confirmed leptospirosis presenting with haemoptysis, arterial hypoxemia (Acute Lung Score < 2.5), haemoglobin drop (>10% from the previous value), or diffused alveolar shadows in the chest radiograph. The above manifestations should not have an alternative explanation.

Exclusion Criteria

- Chronic kidney disease Stages iii, iv, v
- Chronic hepatitis and liver cirrhosis of any etiology (compensated or decompensated)
- Clinically manifested chronic obstructive airway disease, bronchial asthma, lung fibrosis
- Pregnant women
- Patients aged <15 and > 80 years
- Patients who are haemodynamically unstable for TPE will also be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival [During the hospital stay and at the time of discharge from the hospital ]<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath